Evidence map›Paper›PMID 33691640›Full record

ArticleBMC nephrology2021

A novel nonsense variant of the AGXT identified in a Chinese family: special variant research in the Chinese reference genome.

Chang Bao Xu, Xu Dong Zhou, Hong En Xu, Yong Li Zhao, Xing Hua Zhao, Dan Hua Liu, Yong An Tian, Xin Xin Hu, Jing Yuan Guan, Jian Cheng Guo and 2 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC nephrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Chang Bao Xu *The Second Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Xu Dong Zhou *The Second Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Hong En XuThe Second Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Yong Li ZhaoThe Second Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Xing Hua ZhaoThe Second Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Dan Hua LiuThe Second Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Yong An TianBGI College, ZhengZhou University, Zhengzhou, China.
Xin Xin HuThe Second Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Jing Yuan GuanThe Second Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Jian Cheng GuoThe Second Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Wen Xue TangThe Second Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Xia XueAcademy of Medical Sciences, ZhengZhou University, Zhengzhou, China. xue-xiasophia@hotmail.com.
Second Affiliated Hospital of Zhengzhou University · CNZhengzhou University · CN

Funding

Medical Science and Technology Projects in Henan Grant NO. SBGJ2018043Zhengzhou University 18XTZX12004
6 · The paper itself

Abstract

backgroundPrimary hyperoxaluria(PH)is a rare autosomal recessive genetic disease that contains three subtypes (PH1, PH2 and PH3). Approximately 80% of PH patients has been reported as subtype PH1, this subtype of PH has been related to a higher risk of renal failure at any age. Several genetic studies indicate that the variants in gene AGXT are responsible for the occurrence of PH1. However, the population heterogeneity of the variants in AGXT makes the genetic diagnosis of PH1 more challenging as it is hard to locate each specific variant. It is valuable to have a complete spectrum of AGXT variants from different population for early diagnosis and clinical treatments of PH1. CASE PRESENTATION: In this study, We performed high-throughput sequencing and genetic analysis of a 6-year-old male PH1 patient from a Chinese family. Two variants (c.346G > A: p.Gly116Arg; c.864G > A: p.Trp288X) of the gene AGXT were identified. We found a nonsense variant (c.864G > A: p.Trp288X) that comes from the proband's mother and has never been reported previously. The other missense variant (c.346G > A: p.Gly116Arg) was inherited from his father and has been found previously in a domain of aminotransferase, which plays an important role in the function of AGT protein. Furthermore, we searched 110 pathogenic variants of AGXT that have been reported worldwide in healthy local Chinese population, none of these pathogenic variants was detected in the local genomes.

conclusionsOur research provides an important diagnosis basis for PH1 on the genetic level by updating the genotype of PH1 and also develops a better understanding of the variants in AGXT by broadening the variation database of AGXT according to the Chinese reference genome.

Indexed as

Codon, NonsenseAsian PeopleChildChinaGenomeHumansHyperoxaluria, PrimaryMalePedigreeTransaminasesAlanine-glyoxylate transaminaseCodon, NonsenseTransaminasesAGXTLocal genome referencePrimary hyperoxaluria type1Whole-exome sequencing, case report

Identifiers

PMID33691640
PMCPMC7945658
OpenAlexW3135421542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.